Paola Tomassetti - Concepedia

Author

Paola Tomassetti

Also Known As

C Paik, P Tomassetti, P. Tomassetti, Paola Tomassetti, Tomassetti Paola, Tomassetti, P., Tomassetti, Paola, p. Tomassetti

205

Publications

11.3K

Citations

H-Index

Concepts

All Affiliations

University of Bologna IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola European Institute of Oncology University of Verona University of Naples Federico II

About

Paola Tomassetti is an author at University of Bologna specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	39	2.3K
2	Health Sciences	9	9	631
3	Diabetes	2	2	139
4	Allergy	1	1	15
5	Clinical Immunology	1	1	15

Paola Tomassetti

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Everolimus for Advanced Pancreatic Neuroendocrine Tumors James C. Yao, Manisha H. Shah, Tetsuhide Ito, New England Journal of Medicine	2011	2.8K
ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms Gianfranco Delle Fave, Dik J. Kwekkeboom, E. Van Cutsem, Neuroendocrinology	2012	321
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression Francesco Panzuto, Letizia Boninsegna, Nicola Fazio, Journal of Clinical Oncology	2011	294
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours Valentina Ambrosini, Paola Tomassetti, Paolo Castellucci, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyNeuro-oncologyPancreatic CancerMedicinePet-mri	2008	264
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study James C. Yao, Marianne Pavel, Catherine Lombard‐Bohas, Journal of Clinical Oncology	2016	262
Chromogranin A: Is It a Useful Marker of Neuroendocrine Tumors? Davide Campana, Francesca Nori, L Piscitelli, Journal of Clinical Oncology	2007	245
<sup>68</sup>Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors Valentina Ambrosini, Davide Campana, Lisa Bodei, Journal of Nuclear Medicine	2010	229
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Drug Design Development and Therapy	2015	204
Endocrine pancreatic tumors: factors correlated with survival Paola Tomassetti, Davide Campana, L Piscitelli, Annals of Oncology Endocrine OncologyPancreatic CancerEndocrine Pancreatic TumorsMedicineSurgical Pathology	2005	193
Standardized Uptake Values of <sup>68</sup>Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors Davide Campana, Valentina Ambrosini, Raffaele Pezzilli, Journal of Nuclear Medicine	2010	177

Page 1